Clinical Trial Update: A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) [NA]

View source ↗

Summary

A pilot clinical trial is investigating upfront adaptive immunotherapy for children, adolescents and young adults with replication-repair deficient high-grade g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: Daniel Morgenstern | Conditions: High Grade Glioma, Replication Repair Deficient | NA | Status: RECRUITING